| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.eikolifesciences.com | |
| Market Cap | 81.96 Cr. | |
| Enterprise Value(EV) | 82.82 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.53 | Trailing Twelve Months Ending 2023-09 |
| Price-Earning Ratio (PE) | 110.90 | Trailing Twelve Months Ending 2023-09 |
| Industry PE | 37.71 | Trailing Twelve Months Ending 2023-09 |
| Book Value / Share | 29.57 | Trailing Twelve Months Ending 2023-09 |
| Price to Book Value | 2.00 | Calculated using Price: 59.13 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.39 Cr. | 13,860,445 Shares |
| FaceValue | 10 | |
| About Eiko Lifesciences Ltd. | ||
| The company is carrying the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. | ||
| 1 Day |
|
-0.43% |
| 1 Week |
|
-2.52% |
| 1 Month |
|
+2.07% |
| 3 Month |
|
+1.39% |
| 6 Month |
|
-0.38% |
| 1 Year |
|
+58.80% |
| 2 Year |
|
-9.30% |
| 5 Year |
|
-1.65% |
| 10 Year |
|
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 1.06 | 2.60 | 5.35 | 4.16 | 1.32 | 2.34 | 10.53 | 4.05 | 2.65 | |
| Return on Capital Employed (%) | 1.60 | 3.53 | 6.83 | 5.60 | 2.25 | 3.46 | 9.18 | 5.96 | 3.77 | |
| Return on Assets (%) | 1.06 | 2.48 | 4.75 | 3.75 | 1.23 | 2.23 | 5.51 | 2.74 | 2.33 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 3 | 3 | 3 | 6 | 5 | 5 | 13 | 29 | 29 | 37 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 1 | 2 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 3 | 3 | 4 | 6 | 6 | 6 | 17 | 35 | 31 | 40 | |
| Non Curr. Assets | 3 | 3 | 3 | 5 | 5 | 6 | 6 | 22 | 22 | 19 | |
| Curr. Assets | 0 | 1 | 0 | 1 | 1 | 0 | 11 | 12 | 9 | 20 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 3 | 3 | 4 | 6 | 6 | 6 | 17 | 35 | 31 | 40 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
| Net Sales | 0 | 1 | 0 | 0 | 0 | 12 | 25 | 18 | 24 | ||
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | |||
| Total Income | 0 | 1 | 0 | 1 | 0 | 0 | 12 | 26 | 19 | 24 | |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | -11 | -24 | -17 | -23 | |
| PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Depreciation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | |||
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -8 | 4 | |
| Cash Fr. Inv. | -3 | 0 | 0 | -1 | 0 | -1 | -3 | 1 | 1 | ||
| Cash Fr. Finan. | 0 | 3 | 0 | 0 | 2 | 0 | 0 | 8 | 3 | -5 | |
| Net Change | 0 | 0 | 0 | 1 | -1 | 0 | 4 | -4 | 0 | ||
| Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 4 | 0 | 1 |
|
Thu, 09 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication We hereby enclose the copy of newspaper publication giving information of Financial results as specified in Regulation 33 of Listing regulations. The results are published in Financial express (English Newspaper) and Mumbai Lakshadweep (Marathi Newspaper) on 09th November 2023 |
|
Wed, 08 Nov 2023
Financial Results For Quarter And Half Year Ended 30Th September 2023 Financial Results for the Quarter and Half year ended 30th September 2023 |
|
Wed, 08 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Pursuant to Regulation 30 and 33 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations) we would like to inform you that the Board of Directors in their meeting held today i.e. 08th November 2023 inter-alia approved the following matters:1.Considered and approved the Un-audited Financial Results of the Company for the quarter and half year ended on 30th September 2023 along with the Limited review Report given by Statutory Auditor of the Company (Annexure - A).2. Appointment of Mr. Chintan B. Doshi (ICSI Membership No. ACS 36190) as a Company Secretary and Compliance Officer pursuant to section 203 of the Companies Act 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 with immediate effect. |
| Fri, 08 Dec 2023 |
Opening at High
|
Close Below Last Week Low
|
Making Lower Lows for 2 Days
|
High Increase in 1 Year
|
Closing Near 50 SMA
|
Equities
M.F.
Sectors
StockEdge Social